Rhythm Pharmaceuticals, Inc.RYTMNASDAQ
Loading
Gross Profit Growth Recovery in ProgressRecovering
Percentile Rank74
3Y CAGR-48.3%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
-48.3%/yr
Quarterly compound
Percentile
P74
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 14.52% |
| Q3 2025 | 6.61% |
| Q2 2025 | 47.85% |
| Q1 2025 | -23.62% |
| Q4 2024 | 29.30% |
| Q3 2024 | 12.60% |
| Q2 2024 | 12.83% |
| Q1 2024 | 10.28% |
| Q4 2023 | 4.52% |
| Q3 2023 | 18.29% |
| Q2 2023 | 69.04% |
| Q1 2023 | 29.45% |
| Q4 2022 | 104.96% |
| Q3 2022 | -56.41% |
| Q2 2022 | 585.17% |
| Q1 2022 | -19.80% |
| Q4 2021 | 96.15% |
| Q3 2021 | 488.32% |
| Q2 2021 | 341.94% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |